Brief: Avadel Says Court Orders 3.85% Royalty on Lumryz Sales to Jazz
17/09/2025 17:06
Sept 17 (Reuters) - Avadel Pharmaceuticals PLC AVDL.O: AVADEL PHARMACEUTICALS PLC - COURT ORDERS AVADEL CNS TO PAY 3.85% ROYALTY ON LUMRYZ SALES TO JAZZ- SEC FILING AVADEL PHARMACEUTICALS PLC -DISAGREES WITH UNDERLYING JURY DECISION REGARDING VALIDITY OF THE ‘782 PATENT Source text: [ID:n0001104659-25-090694] Further company coverage: AVDL.O
Recent news on Avadel Pharmaceuticals
See all newsBrief: Alkermes PLC Completes Acquisition Of Avadel Pharmaceuticals PLC, Accelerating Entry Into Sleep Medicine Market
NASDAQ TRADE HALT TRADING HALTED; FOR INFORMATION REQUESTED BY NASDAQ AT 08:10 AM
H Lundbeck steps down from takeover for Avadel, shares rise 3%
Deals of the day-Mergers and acquisitions
U.S. STOCKS ON THE MOVE-Viking, Valvoline, Alphabet